Thank You for Your Work, Andreas Steck!
Prof. Andreas Steck, Chairman of the IRP Research Council, is stepping down after 12 years. He is handing over his position to another renowned neuroscience specialist, Prof. James Fawcett of Cambridge. The IRP Foundation Board extends its heartfelt thanks to him for his outstanding work with the research projects that have contributed to IRP’s excellent reputation. Prof. Steck describes his experience over the past years.
«Over the past twelve years, I have had the great privilege of chairing the IRP Research Council. This period has been eventful and marked by significant progress, which for the first time has led to clinical applications in the treatment of patients with paraplegia.
The IRP Research Council reviews the applications submitted each year and selects the most promising projects. Research into paraplegia covers a broad range of areas, from basic research and clinical applications to neurorehabilitation. I would like to mention two projects supported by IRP that illustrate translational research, which aims to translate scientific theories into practical applications.
First, in Lausanne, researchers Grégoire Courtine and Jocelyne Bloch successfully tested STIMO, a revolutionary neurotechnology that combines targeted electrical stimulation of the lumbar spinal cord with a rehabilitation protocol. At present, NISCI is conducting a multicentre study at several major European spinal cord injury centres: the aim is to demonstrate the therapeutic efficacy of antibodies against the Nogo protein.
It should be emphasised that the first promising publications by neurobiologist Martin Schwab were already published in 1990, while the clinical study is expected to be completed in 2023.
Even if everything progresses optimally, it will still take several years before these new therapies can be used in the treatment of spinal cord injuries. Rapid progress is often discussed in medicine; however, research into paraplegia shows that there can sometimes be a long period between the first publications and application in patients. Finding the right balance between selecting applications for basic research projects that are difficult to extrapolate to patients and projects that enable clinical application requires a carefully considered strategy. Ultimately, this was the challenge that the IRP Research Council successfully addressed.
I would like to express my sincere thanks to all members of the Research Council who supported us in this work with their expertise, as well as to the IRP Secretariat for its commitment and the Foundation Board for its support.»
Professor Andreas Steck

Photo: Prof. James Fawcett, Béatrice Brunner, Head of the Zurich Office, and Prof. Andreas Steck at the dinner marking the handover from the outgoing Chairman to his successor.
